The major histocompatibility complex (MHC) class I molecules are designed to present a peptide signature derived from an intracellular pathogen at the plasma membrane, where it can be detected by cytotoxic T lymphocytes (CTLs). The intracellular processes that participate in bringing about this task include protein degradation, translocation, and folding. In this issue of Cell, Ahn and colleagues (Park et al., 2006) add an intriguing new chapter to this complex set of events. These authors describe how the folding of MHC class I molecules is linked to peptide loading by protein disulfide isomerase (PDI), an enzyme in the endoplasmic reticulum (ER). They also show that the US3 protein from human cytomegalovirus has evolved to destroy PDI, thereby obscuring the antigen-presenting function of MHC class I and enabling the virus to evade detection by T cells.
Most peptides presented by MHC class I are derived from cytosolic or nuclear proteins, which are degraded into fragments by the sequential action of the proteasome and cytosolic peptidases. A few peptides escape complete breakdown into amino acids by binding to chaperones or to a dedicated peptide transporter called TAP that localizes to the ER membrane. The luminal domain of TAP acts as a binding platform for a series of chaperones that support the correct folding of MHC class I in the so-called MHC class I peptide-loading complex (Figure 1A) (Cresswell, 2005) . Peptides are translocated into the ER by TAP in a naked form and can then follow different fates. For example, peptides can be trimmed by ER aminopeptidases (sometimes required for generating correct MHC class I binding peptides) or can bind to ER chaperones, albeit with different efficiency. PDI appears to be the most efficient peptide-binding ER chaperone, as it binds to peptides of different length and sequence (Spee et al., 1999) . Peptides bound to PDI will be protected from degradation, which may be helpful unless trimming is required for optimal binding to MHC class I (the optimal size of peptides that bind to MHC class I is usually 9 amino acids). Finally, peptides can be rapidly retrotranslocated into the cytosol. Together, these processes keep the concentration of free peptides low in the ER such that only the most recent peptides in the ER are available for MHC class I binding and do not have to compete with those that arrived earlier (Yewdell et al., 2003) . For immunologically relevant peptide presentation, MHC class I has to select high-affinity binding peptides given that they may need to remain at the surface of antigen-presenting cells like dendritic cells for days while they migrate from peripheral tissues to lymph nodes to initiate a T cell response. It is against this background that we are beginning to understand why the loading of MHC class I with high-affinity peptides in the ER turns out to be such a complex business.
The MHC class I molecule is a heterodimer that is stabilized by binding The loading of peptides into the groove of MHC class I molecules prior to antigen presentation is a complex process. In this issue of Cell, Park et al. (2006) show that peptide loading gets a helping hand from a resident ER enzyme called protein disulfide isomerase, a chaperone that has oxidoreductase activity.
The complex Route to MHc class I-Peptide complexes
to a high-affinity peptide. Only this heterotrimeric form is allowed to leave the ER for transport to the plasma membrane. Peptide loading occurs with the help of the chaperones tapasin, calreticulin, and the oxidoreductase ERp57, which together with the MHC class I heterodimer form the peptideloading complex. Consequently, in the absence of any of these three chaperones, a large fraction of newly synthesized MHC class I molecules escape ER quality control and are released to the cell surface in a suboptimal form. ER chaperones thus directly or indirectly support the loading of high-affinity peptides onto MHC class I under conditions where the concentration of free soluble peptide is negligible.
In their new study, Park et al. (2006) show that the peptide-loading complex is even more crowded than we thought. They demonstrate that a fourth chaperone, PDI, also participates. PDI depletion led to poor peptide loading and the accumulation of MHC class I in which the disulfide bond that underpins the peptide-binding groove (in the H chain α2 domain) is reduced. Interestingly, the same situation arose when peptide supply to the ER was restricted in cells with normal PDI. These experiments provide the best evidence to date that peptide loading and oxidative folding of the MHC class I peptide-binding groove are intimately linked. Interestingly, knockdown of the homologous oxidoreductase ERp57 seems to have less of an obvious effect on the MHC class I oxidation state despite its role in peptide loading (Garbi et al., 2006; Dick et al., 2002) .
Why would the control of disulfide bridge formation in MHC class I heterodimers be essential for peptide editing? One possibility is that the formation of the α2 disulfide bridge may be critical for "setting" the peptide-binding groove in a peptidereceptive state in the peptide-loading complex (analogous to the opening of a Venus flytrap). If, as suggested (Elliott and Williams, 2005) , peptide binding triggers closure of the flytrap, oxidoreductases may be required to reopen it if abortive peptide-capture occurs. PDI might provide the oxidofigure 1. The MHc class I Peptide-Loading Pathway (A) Proteins from pathogens are polyubiquitinated and degraded by the proteasome. The degradation fragments can be further broken down to single amino acids by cytosolic peptidases. Only a few peptides escape this destruction and can be translocated by the peptide transporter TAP into the ER lumen. Here they may bind to MHC class I molecules or chaperones, especially PDI. Alternatively, they are further trimmed by the aminopeptidase ERAP or retrotranslocated back into the cytosol by the ERAD system. Most MHC class I molecules acquire peptides in the peptide-loading complex (boxed) consisting of TAP; the MHC class I heterodimer; and the chaperones tapasin, ERp57, and calreticulin. PDI is a new component of this complex and controls an oxidation step that may be essential to clamp the MHC class I peptide-binding groove. (B) The selection of high-affinity peptide cargo and the oxidation of the α2 disulfide bridge in MHC class I molecules may be linked processes. It is possible that class I molecules with a fully oxidized peptide-binding groove sample incoming peptides delivered by TAP. Upon encountering peptide, MHC class I may close around it, resulting in a more stable interaction. Oxidoreductases may be important for regenerating a receptive peptide-binding groove in the (possibly frequent) event that low-affinity peptides dissociate from the closed/closing molecule. PDI may do this job alone or in concert with the other oxidoreductase in the peptide-loading complex, ERp57 (boxed).
reductase activity alone or in combination with proximal ERp57 molecules. Notably, under steady-state conditions, the total pool of PDI in the ER is predominantly oxidized. In contrast, the oxidoreductase ERp57 (at least in the peptide-loading complex) is predominantly in the reduced state (Dick et al., 2002) . These two enzymes may collaborate to reduce (ERp57) and oxidize (PDI) MHC class I in iterations of peptide binding events that are part of editing the peptide repertoire ( Figure 1B) .
Intriguingly, unlike ERp57, PDI efficiently binds to peptides (Spee et al., 1999) and thus may have a dual role in MHC class I loading-that is, both folding and peptide delivery. Park et al. (2006) were unable to separate these activities but speculate that this could be the case for two reasons. First, preventing the binding of peptides to PDI by mutating its peptidebinding site also prevented correct oxidation of MHC class I molecules (albeit to a lesser extent). Second, blocking peptide transport into the ER inhibited MHC class I oxidation.
Possibly, peptide supply is required for PDI-directed MHC class I folding. Thus, PDI may set the trap and deliver a peptide directly to the waiting jaws of the MHC class I peptide-binding groove. It is equally possible that peptides are just cofactors for PDI activity or that the peptide-binding site of PDI represents a "foldase" active site. This remains to be established.
Finally, Park et al. (2006) provide an evolutionary argument for the relevance of PDI activity in the antigenpresentation pathway. In the "struggle for survival," human cytomegalovirus targets various steps in the MHC class I antigen-processing pathway as a stealth strategy to avoid immune detection. In prior work, Park et al. (2004) showed that one of these proteins, US3, binds to TAP, MHC class I heavy chain, and tapasin, thereby inactivating the peptide-editing function of the latter. They now show that US3 also targets PDI for degradation, thus reducing the capacity of infected cells to present antigens. PDI degradation also affects other folding processes, as "only" 15% of available PDI is busy inducing MHC class molecules to fold. As Park and colleagues elegantly demonstrate, viral interest in PDI as a target for degradation confirms the importance of chaperone proteins for successful antigen presentation under normal conditions.
Molecular chaperones, such as eukaryotic heat shock protein 90 (hsp90), promote the correct folding of client proteins. Biochemical studies have shown that hsp90 is an ATPdriven machine that cooperates with a set of cochaperones (Riggs et al., 2004) . Although the domain architecture of hsp90 is conserved between E. coli and man, none of the cochaperones that aid in hsp90 function in the eukaryotic cell have been found in prokaryotes. In this issue, Shiau et al. (2006) present the crystal structure of the archetypal hsp90 chaperone in E. coli, HtpG. The new structures reveal the dramatic conformational changes in HtpG that accompany its ATPase cycle.
The hsp90 protein is modular with three well-defined domains, an N-terminal ATP binding domain, a middle domain that completes the ATPase site and binds to client pro-
